2019 Volume 44 Issue 5 Pages 903-910
A fifty-year-old man, diagnosed as having stage Ⅳ gastric cancer (metastasis of the para-aortic lymph nodes and left supraclavicular lymph nodes), received nine courses of S-1 plus oxaliplatin. The metastatic lymph nodes decreased in size, and we performed a gastrectomy with a D2 – No. 10 + No. 16a2/b1 lymph node dissection. Histopathological findings showed gastric cancer to Stage ⅡA and he underwent adjuvant chemotherapy with S-1. One year after the first surgery, an abdominal CT scan revealed metastasis to the spleen. The patient received one course of capecitabine plus oxaliplatin and eight courses of paclitaxel plus ramucirumab. After the chemotherapy regimens, the size of the tumor remained stable and the patient underwent a splenectomy. He received postoperative adjuvant chemotherapy and has been alive without relapse. We consider that this is informative for conversion surgery in cases of gastric cancer.
